2024年12月12日乳腺癌文献共享

学术   2024-12-12 15:20   上海  


N Engl J Med. 2024 Dec 11. IF: 96.2
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer.
www.nejm.org/doi/10.1056/NEJMoa2410858

Nat Med. 2024 Dec 11. IF: 58.7
Self-improving generative foundation model for synthetic medical image generation and clinical applications.
www.nature.com/articles/s41591-024-03359-y

Ann Oncol. 2024 Dec 11. IF: 56.7
Genomic correlates of response and resistance to the irreversible FGFR1-4 inhibitor futibatinib based on biopsy and circulating tumor DNA profiling.
www.annalsofoncology.org/article/S0923-7534(24)04976-7/fulltext

Nature. 2024 Dec 11. IF: 50.5
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.
www.nature.com/articles/s41586-024-08305-z

Nature. 2024 Dec 11. IF: 50.5
π-HuB: the proteomic navigator of the human body.
www.nature.com/articles/s41586-024-08280-5

Adv Mater. 2024 Dec 10:e2411259. IF: 27.4
Single-Cell Isolation Chip Integrated with Multicolor Barcode Array for High-Throughput Single-Cell Exosome Profiling in Tissue Samples.
www.onlinelibrary.wiley.com/doi/10.1002/adma.202411259

Nat Cancer. 2024 Dec 11. IF: 23.5
Mapping the functional network of human cancer through machine learning and pan-cancer proteogenomics.
www.nature.com/articles/s43018-024-00869-z

Cancer Commun (Lond). 2024 Dec 10. IF: 20.1
Cancer situation in China: an analysis based on the global epidemiological data released in 2024.
www.onlinelibrary.wiley.com/doi/10.1002/cac2.12627

Adv Sci (Weinh). 2024 Dec 11. IF: 14.3
Tumor Microenvironment-Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression.
www.onlinelibrary.wiley.com/doi/10.1002/advs.202405845

Small. 2024 Dec 10. IF: 13.0
A Magnetically Actuated MOF-Based Nanozyme for Intensified Induction of Ferroptosis and Immunogenic Cell Death Via Autophagy Blockade.
www.onlinelibrary.wiley.com/doi/10.1002/smll.202409026

J Natl Cancer Inst. 2024 Dec 11. IF: 9.9
Impact of radiotherapy dose, fractionation and immunotherapeutic partner in a mouse model of HR+ mammary carcinogenesis.
www.academic.oup.com/jnci/article/7921421





































SIBCS
上海国际乳腺癌论坛(Shanghai International Breast Cancer Symposium)
 最新文章